The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sergeev A.V.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Non-invasive neurostimulation in migraine

Authors:

Sergeev A.V.

More about the authors

Read: 4272 times


To cite this article:

Sergeev AV. Non-invasive neurostimulation in migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6):114‑118. (In Russ.)
https://doi.org/10.17116/jnevro2020120061114

Recommended articles:
Oxidative stress in the pathogenesis of chro­nic headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):35-40
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712

References:

  1. Saylor D, Steiner TJ. The Global Burden of Headache. Semin Neurol. 2018;38(2):182-190. 
  2. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-976. 
  3. Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2015;35(6):478-488. 
  4. Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, Wilcox TK, Kawata AK, Lipton RB. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53(4):644-655. 
  5. Jürgens TP, Leone M. Pearls and pitfalls: neurostimulation in headache. Cephalalgia. 2013;33(8):512-525. 
  6. Reuter U, McClure C, Liebler E, Pozo-Rosich P. Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials. J Neurol Neurosurg Psychiatry. 2019;90(7):796-804. 
  7. Largii S. Ad Capitis Dolorem. 1st century BC. 
  8. DeSantana JM, Da Silva LF, De Resende MA, Sluka KA. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience. 2009;163(4):1233-1241.
  9. Cruccu G, Aziz TZ, Garcia-Larrea L, Hansson P, Jensen TS, Lefaucheur JP, Simpson BA, Taylor RS. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007;14(9):952-970. 
  10. Martelletti P, Jensen RH, Antal A, Arcioni R, Brighina F, de Tommaso M, Franzini A, Fontaine D, Heiland M, Jürgens TP, Leone M, Magis D, Paemeleire K, Palmisani S, Paulus W, May A. Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain. 2013;14(1):86. 
  11. Isagulyan EL, Osipova VV, Ekusheva EV, Sergeed AV, Artemenko AV. Neiromodulyatsiya d lechenii clasternoi golovnoj boli. RMZf. 2017; 24: 1779-1784.
  12. Schoenen J, Roberta B, Magis D, Coppola G. Noninvasive neurostimulation methods for migraine therapy: The available evidence. Cephalalgia. 2016;36(12):1170-1180.
  13. Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial. Cephalalgia. 2019;39(1):3-14. 
  14. Kuruvilla D, Mann J, Schoenen J, Penning S. Acute treatment of migraine with external trigeminal nerve stimulation: A pilot trial. Cephalalgia Reports. 2019;2:1-6. 
  15. Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gérard P, Magis D. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80:697-704. 
  16. Di Fiore P, Bussone G, Galli A, Didier H, Peccarisi C, D’Amico D, Frediani F. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial. Neurol Sci. 2017;38(suppl 1):201-206. 
  17. Rodríguez-Osorio X, López-González FJ, Garamendi Í. VNS and pregnancy: A multicentric experience of four cases. Acta Neurol Scand. 2017;136(4):372-374. 
  18. Suller Marti A, Mirsattari SM, Steven DA. Experience on the use of Vagus nerve stimulation during pregnancy. Epilepsy Res. 2019;156:106-108. 
  19. Esparham A, Herbert A, Pierzchalski E, Tran C, Dilts J, Boorigie M, Wingert M, Connelly M, Bickel J. Pediatric Headache Clinic Model: Implementation of Integrative Therapies in Practice. Children (Basel). 2018;5(6):74. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.